Writing as medicine: can words soothe chronic pain?

NCT ID NCT07058532

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This study looks at whether a guided therapeutic writing program can help adult women with chronic pain and co-occurring mental health conditions. Participants will complete writing exercises focused on emotional processing and meaning-making over four weeks, then share their experiences in interviews. Researchers will use qualitative methods to understand how writing may support emotional regulation and well-being during pain rehabilitation. The goal is to see if writing offers a useful, non-drug complement to standard pain care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A guided therapeutic writing intervention delivered in two phases over four weeks, designed to support emotional processing and regulation in women with chronic pain and co-occurring mental health conditions.
What this could lead to
If writing helps, it could offer a low-risk, non-drug tool to support emotional processing and well-being during pain rehabilitation.
What could go wrong
This is a small observational study, so it cannot prove cause and effect. Results may not apply to all people with chronic pain, and writing may not ease pain for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult women (18 years or older), assigned female at birth and self-identify as women * Diagnosed with or experience of chronic, widespread (non-cancer) pain lasting at least two years * Diagnosed with or living with one or more mild mental health disorders (e.g., anxiety, mild depression), without current or past severe psychiatric conditions * Diagnosed with or experience of nociplastic pain (e.g., fibromyalgia) * Not currently using medications that may impair cognitive functioning (e.g., benzodiazepines, anticholinergics, opioids, antipsychotics) * Able to attend approximately 11 in-person visits over a 3-month period * Willing and able to participate in a structured therapeutic writing intervention * Purposefully selected to reflect a range of lived experiences relevant to the study's aims Exclusion Criteria: * Presence of severe mental health disorders (e.g., schizophrenia, bipolar disorder, severe depression, or other psychotic conditions) * Use of medications known to impair memory, attention, or decision-making (e.g., benzodiazepines, anticholinergics, opioids, antipsychotics) * Participation in other concurrent treatments that may influence study outcomes * Cognitive limitations that would hinder meaningful engagement in the writing intervention * Individuals not assigned female at birth or who do not identify as women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety disorders are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Satasairaala Hospital, Department of Physical Medicine and Rehabilitation: Pain Clinic

    Pori, Satakunta, 28500, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.